Chinese biotech Minghui Pharmaceutical has sold certain rights to its experimental cancer drug MHB088C to Qilu Pharmaceutical ...

Spanish dermatology specialist Almirall was the envy of investors on Monday, with its share price closing 10% higher.

Swiss pharma giant Roche is investing $280 million to build a new biopharma manufacturing facility in Shanghai, as it doubles ...

US healthcare giant Johnson & Johnson has announced new data from the Phase III ICONIC-TOTAL study investigating icotrokinra ...

Japanese drugmaker Shionogi (TYO: 4507) has entered into a joint research agreement with French firm Cilcare for the creation ...

Boston, USA-based biotech Aera Therapeutics, which is harnessing next-generation enabling delivery technologies and precision ...

The UK’s BioIndustry Association (BIA) has publishes its 10-year Vision for the UK life science sector called “A Vision for ...

US pharma major Eli Lilly (NYSE: LLY) announced a significant expansion of its long-standing alliance with Purdue University, ...

Denmark, oncology-based Pharmacosmos today announced that it has assumed the worldwide rights, excluding select Asia-Pacific ...

N) today presented data from the Phase III REAL8 basket study, which showed that once-weekly Sogroya (somapacitan) was ...

Shine Technologies, a private nuclear fusion corporation based in Wisconsin, USA, has entered into a definitive agreement to ...

New figures from European industry group EFPIA paint a stark picture of the growing divide in access to innovative medicines ...